TG THERAPEUTICS, INC. (TGTX) Operating cash flow 2016–2025
TG THERAPEUTICS, INC. (TGTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.8MFY2025 · since FY2016: -$61.6M → -$24.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.8M | +38.9% |
| FY2024 | -$40.5M | -29.0% |
| FY2023 | -$31.4M | +82.2% |
| FY2022 | -$176.2M | +40.4% |
| FY2021 | -$295.6M | -37.8% |
| FY2020 | -$214.5M | -61.5% |
| FY2019 | -$132.8M | -3.0% |
| FY2018 | -$128.9M | -37.5% |
| FY2017 | -$93.8M | -52.2% |
| FY2016 | -$61.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice